NANUET, N.Y. - (Business Wire) iMedicor (OTCBB: VMCI) today announced it has received a Scope of Work (SOW) order from its partner, Franklyn Ideas, LLC (Franklyn) on behalf of one of its major pharmaceutical clients. The project calls for the direct marketing of pharma products via iMedicor’s HIPAA-compliant portal utilizing a proprietary system that will allow the client to target specific physician groups in their marketing efforts. This SOW is the first of many such projects envisioned by the two companies when they executed a Strategic Alliance Agreement disclosed in Vemics’ Form 10-K filed on October 13, 2009. http://www.sec.gov/Archives/edgar/data/1408057/000118518509001039/vemics-10k63009.htm The project is expected to launch by January 2010.
“We are extremely pleased that our combined efforts this year have resulted in iMedicor’s deployment of this innovative approach to on-line pharmaceutical marketing with one of Franklyn Ideas key clients,” said Fred Zolla, CEO of iMedicor. “Our technology will allow their client to market directly to highly profiled medical practices and healthcare providers, and we look forward to using our success with this launch to build other relationships with Franklyn Ideas.”
“iMedicor represents a disruptive approach for reaching a distinct, targeted market with specific messages” said Stacey Richter, President and Founder of Franklyn Ideas, “We are excited about the potential this new approach represents for our client base.”
iMedicor has recently announced Transgenomic and Access Pharmaceutical companies as early adopters of its marketing service. This SOW represents the first in what is expected to be several additional clients and users of the iMedicor Pharma Marketing Platform over the next six months.
About iMedicor:
iMedicor is the only HIPAA-compliant solution for interoperable medical information transfer that is offered at no cost to healthcare providers and patients. The iMedicor portal also enables pharmaceutical companies to deliver customized marketing programs to more than 730,000 healthcare providers nationwide in a highly targeted, cost-effective and non-intrusive manner; allows doctors, administrators and other qualified healthcare workers to send and receive medical records, files and images; and enables disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time. More information on iMedicor is available at www.imedicor.com.
The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of iMedicor’s products and services; the nonexclusive and terminable-at-will nature of certain of the company's partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filing s with the Securities and Exchange Commission.
iMedicor
Investor:
Craig Stout, 845-356-5211
Chief Operating Officer
cstout@imedicor.com
or
Media:
Aimee Whitelaw, 202-997-1114
Communications Adviser
awhitelaw@imedicor.com
